Slides
Page 1
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q2 & H1 2026 Financial Results Conference call | August 27, 2026 www.materialise.com | NASDAQ & EURONEXT : MTLS
Page 2
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Safe Harbor Summary 2 This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among other things, our estimates for revenue, Adjusted EBITDA, Adjusted EBIT, our results of operations, cash needs, capital expenditures, expenses, financial condition, liquidity, prospects, growth and strategies (including how our business, results of operations and financial condition could be impacted by the current armed geopolitical conflicts around the world and governmental responses thereto, inflation, increased labor, energy and materials costs), policy changes resulting from the U.S. presidential administration, changes in tariffs and trade restrictions, and the trends and competition that may affect the markets, industry or us. Such statements are subject to known and unknown uncertainties and risks. When used in this presentation, the words “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “will,” “may,” “could,” “might,” “aim,” “should,” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this presentation. These expectations, beliefs and projections are expressed in good faith and the company believes there is a reasonable basis for them. However, the company cannot offer any assurance that our expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of the forward-looking statements are subject to risks and uncertainties that may cause the company's actual results to differ materially from our expectations, including risk factors described in the company's annual report on Form 20-F filed with the U.S. Securities and Exchange Commission. There are a number of risks and uncertainties that could cause the company's actual results to differ materially from the forward-looking statements contained in this presentation. This presentation includes non-IFRS financial measures, including EBIT, EBITDA, Adjusted EBIT and Adjusted EBITDA. These measures are supplemental measures of financial performance that are not required by, or presented in accordance with, international financial reporting standards (“IFRS”). Please refer to the Appendix of this presentation for a reconciliation of such non-IFRS financial measures to the most directly comparable financial measures prepared in accordance with IFRS.
Page 3
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours • Q2 2026 Business Highlights • Q2 2026 Financial Highlights • Q2 & H1 2026 Financial Results • 2026 Financial Guidance • Q&A Agenda Koen Berges CFO Brigitte de Vet-Veithen CEO 3
Page 4
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q2 2026 Business Update H1 report published • To be consulted on our Investor Relations website • In compliance with Euronext requirements Strengthening Executive Committee • CHRO: Annelies Missotten • CDIO: Philippe Verlinde • EVP Medical Koen Peters leaving the company 30 year anniversary of Materialise in the U.S. • Instrumental in global success • Driver of various strategic acquisitions
Page 5
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Medical – Making the ExceptionalAccessible • Hospital Forum reflects continued maturation of the personalized care market • Investment in Replasia expands Materialise’s personalized hip care portfolio • Materialise offers complete minimally invasive MIOS workflow Software – Growing Our Software Ecosystem • Continued rollout of CO -AM with release of CO -AM Pro • Early adopter programs for NPI and Enterprise versions of CO -AM Manufacturing – Delivering Certified Additive Manufacturing Solutions • Portfolio choices: Completed the divestiture of RapidFit and Eyewear business • Aerospace: ▪ +40% YoY revenue growth ▪ Materialise named official Workbench for Lufthansa Technik metal parts • Defense: Materialise leads consortium to strengthen trusted access to spare parts for Belgian defense Q2 2026 Business Update
Page 6
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q2 2026 – Financial Highlights • Revenue of 70.1 mEUR, representing an increase of 8.1% from Q2 2025 • Gross Profit of 39.8 mEUR, representing 56.8% of revenue • Adjusted EBIT of 3.9 mEUR, representing 5.5% of revenue • Net profit of 3.3 mEUR, representing 6 EUR-ct. per share • Net Cash position of 74.2 mEUR, representing an increase of 3.4 mEUR from year-end 2025, while YTD 5.2 mEUR was invested in share buybacks 6
Page 7
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q2 & Half-Year 2026 Consolidated Revenue • Quarterly revenue of 70.1 mEUR, representing an increase of 8.1% compared to Q2 2025 • Q2 revenue growth of 12% in our Medical segment. Manufacturing segment shows 7% Q2 growth driven by strong performance of our series manufacturing focus segments. • 46.5 mEUR of deferred revenue from software licenses and maintenance carried on our balance sheet at the end of Q2 2026 14% 53% 34% Software Medical Manufacturing Q2 2026 Revenue by Segment 7 [Data in kEUR unless notes otherwise. All numbers and percentages rounded] Q2 2025 Q2 2026 64,831 70,073 +8.1% HY 2025 HY 2026 131,210 136,349 +3.9%
Page 8
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q2 & Half-Year 2026 Consolidated Adjusted EBITDA & EBIT Adj. EBITAdj. EBITDA 8 [Data in kEUR unless noted otherwise. All numbers and percentages rounded] Q2 2025 Q2 2026 3,058 3,880 +26.9% HY 2025 HY 2026 3,703 6,351 +71.5% Q2 2025 Q2 2026 8,288 9,593 +15.7% HY 2025 HY 2026 14,434 17,642 +22.2% 11.0% 12.9% 13.7% 12.8% 4.7% 2.8%5.5% 4.7% • Significant growth in Adjusted EBIT and Adjusted EBITDA compared to PY both in Q2 as well as throughout H1 2026 • Increased revenue combined with continued cost control drive higher operational profitability
Page 9
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q2 & Half-Year 2026 Medical Segment • Q2 2026 revenue increased 12% to 36.9 mEUR • Revenue from medical devices & services increased 19%, driven by growth in both partner and direct sales • Revenue from medical software decreased by -4% • Q2 2026 Adjusted EBITDA grew to 11.6 mEUR, representing an Adjusted EBITDA margin of 31% 9 [Data in kEUR unless noted otherwise. All numbers and percentages rounded] Revenue Adj. EBITDA Q2 2025 Q2 2026 32,850 36,873 +12.2% HY 2025 HY 2026 63,928 70,039 +9.6% Q2 2025 Q2 2026 10,728 11,553 +7.7% HY 2025 HY 2026 19,775 20,787 +5.1% 30.9% 29.7% 31.3%32.7%
Page 10
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q2 & Half-Year 2026 Software Segment • Q2 2026 revenue decreased by 2.7% to 9.6 mEUR compared to Q2 2026 • Recurring revenue representing 86% of total revenue in Q2 2026 • Q2 2026 Adjusted EBITDA decreased to 1.0 mEUR, representing an Adjusted EBITDA margin of 10%. Over H1 2026 Adj. EBITDA increased by 7% to 2.1 mEUR 10 [Data in kEUR unless noted otherwise. All numbers and percentages rounded] Revenue Adj. EBITDA Q2 2025 Q2 2026 9,872 9,601 -2.7% HY 2025 HY 2026 19,647 19,242 -2.1% 981 Q2 2025 Q2 2026 1,373 -28.6% HY 2025 HY 2026 1,971 2,103 +6.7% 10.0% 10.9% 10.2% 13.9%
Page 11
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q2 & Half-Year 2026 Manufacturing Segment • Q2 2026 revenue increased by 6.7% to 23.6 mEUR compared to Q2 2025 • Revenue growth is driven by strategic segments in series manufacturing partly offset by continued soft prototyping demand • Q2 2026 Adjusted EBITDA improved to (0.3) mEUR. Over H1 2026 Adj EBITDA improved to breakeven level. 11 [Data in kEUR unless noted otherwise. All numbers and percentages rounded] Revenue Adj. EBITDA Q2 2025 Q2 2026 22,109 23,597 +6.7% HY 2025 HY 2026 47,635 47,067 -1.2% -807 -285 Q2 2025 Q2 2026 -4 HY 2025 HY 2026 -1,185 -2.5% -0.0% -1.2% -3.6%
Page 12
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Income Statement Highlights Q2 Half-Year (in thousands of euros, except where indicated) 2026 2025 2026 2025 Revenue 70,073 64,831 136,349 131,210 Cost of sales (30,297) (27,053) (58,679) (56,708) Gross profit 39,776 37,778 77,670 74,502 Research & development expenses (12,312) (11,120) (24,203) (22,534) Sales & marketing expenses (15,209) (15,471) (30,644) (30,542) General & administrative expenses (10,236) (9,744) (19,623) (19,769) Other income/(expenses), net 766 1,286 1,676 1,646 Operating profit/(loss) 2,785 2,730 4,875 3,303 Financial income/(expenses), net 242 (3,052) 634 (3,927) Taxes 304 521 (358) 287 Net profit/(loss) 3,331 199 5,152 (337) Diluted EPS (in EUR) 0.06 0.00 0.09 (0.01) (Diluted) weighted average shares (thousands) 58,329 59,067 58,592 59,067 12 Q2 2025 Q2 2026 HY 2025 HY 2026 58.3% 56.8% 56.8% 57.0% Gross profit margin (in %) Diluted EPS (in EUR) Q2 2025 Q2 2026 HY 2025 HY 2026 0.00 0.06 0.01 0.09 [Data in kEUR unless noted otherwise. All numbers and percentages rounded]
Page 13
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Other Financial Highlights Balance Sheet items (in thousands of euros, except where indicated) 30/06/26 12/31/25 Cash and equivalents 133,735 133,918 Borrowings 59,521 63,113 Net Cash 74,214 70,805 Trade receivables 56,173 54,938 Inventories 16,846 14,904 Trade payables 19,382 20,125 Deferred income 62,553 60,867 Equity 256,268 255,482 Total balance sheet 417,665 420,646 13 Cash flow from operations Capital expenditures (cash impact) [Data in kEUR unless noted otherwise. All numbers and percentages rounded] Q2 2025 Q2 2026 HY 2025 HY 2026 27 8,146 9,686 15,060 Q2 2025 Q2 2026 HY 2025 HY 2026 4,729 1,975 6,561 3,445
Page 14
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours 2026 Financial Guidance 14 We maintain our previous revenue guidance but increase our Adjusted EBIT guidance based on solid H1 results • Expect 2026 consolidated revenue within 273 - 283 mEUR range • Expect 2026 consolidated Adjusted EBIT within 12 - 14 mEUR range, revised upwards from our previous range of 10 – 12 mEUR
Page 15
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Adjusted EBIT/EBITDA Reconciliation Appendix Q2 Half-Year [Data in kEUR unless noted otherwise. All numbers and percentages rounded] 2026 2025 2026 2025 Net profit/(loss) 3,331 199 5,152 (337) Income taxes (304) (521) 358 (287) Financial expenses 871 4,039 1,571 6,811 Financial income (1,113) (987) (2,205) (2,884) EBIT 2,785 2,730 4,876 3,303 Depreciation & amortization 5,712 5,230 11,291 10,731 EBITDA 8,497 7,960 16,167 14,034 Share-based compensation expense 59 45 115 117 Restructuring and corporate initiatives 178 283 435 283 Impairments 689 - 756 - Divestitures-related expenses 169 - 169 - Adjusted EBITDA 9,593 8,288 17,642 14,434 Depreciation & amortization (5,712) (5,230) (11,291) (10,731) Adjusted EBIT 3,880 3,058 6,351 3,703 15
Page 16
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Thank You Contact: Investor Relations Materialise investors@materialise.com 16